Skip to main content

Lampit FDA Approval History

Last updated by Judith Stewart, BPharm on Jan 27, 2021.

FDA Approved: Yes (First approved August 6, 2020)
Brand name: Lampit
Generic name: nifurtimox
Dosage form: Tablets
Company: Bayer HealthCare Pharmaceuticals Inc.
Treatment for: Chagas Disease

Lampit (nifurtimox) is a nitrofuran antiprotozoal used for the treatment of Chagas disease (American Trypanosomiasis) in pediatric patients.

Development timeline for Lampit

Aug  7, 2020Approval FDA Approves Lampit (nifurtimox) for the Treatment of Chagas Disease in Children

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.